ストックスクリーナーアプリを入手
3.62
0.55%
-0.02
アフターアワーズ：
3.63
0.010
+0.28%
前日終値:
$3.64
開ける：
$3.58
24時間の取引高:
5.43M
Relative Volume:
1.11
時価総額：
$988.12M
収益：
$251.85M
当期純損益:
$-72.58M
株価収益率:
-11.55
EPS:
-0.3134
ネットキャッシュフロー:
$-63.80M
1週間 パフォーマンス:
-12.35%
1か月 パフォーマンス:
-19.56%
6か月 パフォーマンス:
-28.60%
1年 パフォーマンス:
-55.09%
1日の値動き範囲:
$3.56
$3.71
1週間の範囲:
$3.50
$4.18
52週間の値動き範囲:
$3.50
$8.1391
Ardelyx Inc Stock (ARDX) Company Profile
ARDX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
3.62 | 988.12M | 251.85M | -72.58M | -63.80M | -0.3134 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-02 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | 再開されました | Ladenburg Thalmann | Buy |
| 2025-03-04 | 開始されました | BTIG Research | Buy |
| 2024-11-11 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | 開始されました | Leerink Partners | Outperform |
| 2023-12-18 | 開始されました | Raymond James | Strong Buy |
| 2023-09-07 | 開始されました | H.C. Wainwright | Buy |
| 2023-08-25 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | アップグレード | Wedbush | Neutral → Outperform |
| 2022-11-17 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | ダウングレード | Jefferies | Buy → Hold |
| 2021-07-20 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | ダウングレード | Wedbush | Outperform → Neutral |
| 2021-03-23 | 開始されました | Wedbush | Outperform |
| 2021-01-06 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-10-20 | 再開されました | Citigroup | Buy |
| 2020-02-18 | 再開されました | Jefferies | Buy |
| 2020-02-12 | 開始されました | Citigroup | Buy |
| 2020-02-10 | 開始されました | Cowen | Outperform |
| 2019-04-08 | 開始されました | Piper Jaffray | Overweight |
| 2018-08-24 | 開始されました | Jefferies | Buy |
| 2018-03-19 | 再開されました | Leerink Partners | Outperform |
| 2017-11-29 | 繰り返されました | Citigroup | Buy |
| 2017-11-22 | 繰り返されました | Ladenburg Thalmann | Buy |
| 2017-10-17 | 再開されました | Leerink Partners | Outperform |
| 2016-03-31 | 開始されました | Ladenburg Thalmann | Buy |
| 2016-03-09 | 開始されました | Cantor Fitzgerald | Buy |
| 2016-03-03 | 開始されました | Citigroup | Buy |
すべてを表示
Ardelyx Inc (ARDX) 最新ニュース
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 15, 2024 in Ardelyx LawsuitARDX - ACCESS Newswire
Ardelyx, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Ardelyx, Inc. (ARDX) - ACCESS Newswire
David Mott Bought 19% More Shares In Ardelyx - simplywall.st
Shareholders that lost money on Ardelyx, Inc.(ARDX) should contact Levi & Korsinsky about pending Class ActionARDX - ACCESS Newswire
Ardelyx, Inc. Class Action: Levi & Korsinsky Reminds Ardelyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - ACCESS Newswire
Levi & Korsinsky Notifies Shareholders of Ardelyx, Inc.(ARDX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Investors who lost money on Ardelyx, Inc.(ARDX) should contact Levi & Korsinsky about pending Class ActionARDX - ACCESS Newswire
Shareholders that lost money on Ardelyx, Inc. (ARDX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Ardelyx, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationARDX - ACCESS Newswire
ARDX LAWSUIT ALERT: Levi & Korsinsky Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
Levi & Korsinsky Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - ACCESS Newswire
Ardelyx, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your RightsARDX - ACCESS Newswire
(ARDX) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Ardelyx downgraded at Raymond James after Q1 sales miss - MSN
Ardelyx presents data supporting IBSRELA at DDW 2025 - TipRanks
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc.ARDX - PR Newswire
Ardelyx First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Hedge Fund and Insider Trading News: Paul Tudor Jones, Warren Buffett, John Paulson Bill Ackman, Platinum Asset Management, Ardelyx Inc (ARDX), Stem Inc (STEM), and More - Insider Monkey
Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digesti - GuruFocus
Ardelyx (ARDX) Highlights IBSRELA's Efficacy at Digestive Diseas - GuruFocus
Ardelyx (ARDX) Highlights IBSRELA's Efficacy at Digestive Disease Week Conference | ARDX Stock News - GuruFocus
Ardelyx showcases IBSRELA data at Digestive Disease Week - Investing.com
Ardelyx showcases IBSRELA data at Digestive Disease Week By Investing.com - Investing.com South Africa
Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference - TradingView
Triple Study Results: IBSRELA IBS-C Drug Proves Safe for Teens and Nursing Mothers at DDW 2025 - Stock Titan
Ardelyx, Inc. (NASDAQ:ARDX) Q1 2025 Earnings Call Transcript - Insider Monkey
Ardelyx Inc Reports Strong Growth Amid Challenges - MSN
Ardelyx targets $240M-$250M in IBSRELA 2025 sales amid strong Q1 growth - MSN
Analysts Have Been Trimming Their Ardelyx, Inc. (NASDAQ:ARDX) Price Target After Its Latest Report - Yahoo Finance
Raymond James cuts Ardelyx stock rating, lowers target to $11 By Investing.com - Investing.com Canada
Ardelyx (ARDX) Price Target Lowered by Citigroup to $10.00 | ARDX Stock News - GuruFocus
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Ardelyx, Inc.(ARDX) Shareholders - ACCESS Newswire
Ardelyx Inc earnings missed by $0.06, revenue fell short of estimates - Investing.com Australia
Raymond James cuts Ardelyx stock rating, lowers target to $11 - Investing.com Australia
Ardelyx (ARDX) Faces Downgrade Amid Revenue Shortfall - GuruFocus
Ardelyx's Q1 Loss Widens; Shares Fall - marketscreener.com
Ardelyx stock downgraded at Raymond James (ARDX:NASDAQ) - Seeking Alpha
Ardelyx: Revenue Misses And Losses Widen Amid XPHOZAH Uncertainty (NASDAQ:ARDX) - Seeking Alpha
Stocks in play: SECURE Waste Infrastructure Corp. - The Globe and Mail
Block, Atlassian, Apple, Roku, Amazon And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Raymond James Downgrades Ardelyx to Outperform From Strong Buy, Adjusts Price Target to $11 From $13 - marketscreener.com
Ardelyx (ARDX) Downgraded by Raymond James Amid Sales Concerns | - GuruFocus
Ardelyx (ARDX) Price Target Reduced by Citi After Q1 Report | AR - GuruFocus
Ardelyx (ARDX) Downgraded by Raymond James Amid Sales Concerns | ARDX Stock News - GuruFocus
Ardelyx (ARDX) Price Target Reduced by Citi After Q1 Report | ARDX Stock News - GuruFocus
Why Twilio Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Shareholders of Ardelyx, Inc. Should Contact Levi & Korsinsky Before October 15, 2024 to Discuss Your RightsARDX - ACCESS Newswire
Ardelyx Inc (ARDX) Q1 2025 Earnings Call Highlights: Robust Revenue Growth Amid Market Challenges - Yahoo
Shareholders that Lost Money on Ardelyx, Inc. (ARDX) Should Contact Levi & Korsinsky About Pending Class ActionARDX - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
Ardelyx (ARDX) Sees Revenue Surge in Q1 2025 - GuruFocus
Ardelyx Inc (ARDX) 財務データ
収益
当期純利益
現金流量
EPS
0.84%
0.15%
大文字化:
|
ボリューム (24 時間):